In climacteric women, with increased risk for obesity, MS becomes more prevalent, increasing the incidence of cardiovascular disease and the risk of acute myocardial infarction (AMI)[57], a vulnerability attributed to the decrease of oestrogen and insulin resistance[58]. This evidence concerns the gene INS and obesity disorder.